The Respiratory Drug Delivery (RDD) Europe 2017 Conference was held in Antibes, France from 26-28 April 2017, and was attended by around 500 people from the inhaler sector of the medical devices industry, together with clinicians and other interested parties. The conference program included plenary sessions, workshops and poster sessions on a comprehensive range of topics.
Dr. Maria E. Donawa, DLC's President, presented on the second day of the conference, advising attendees on how impact of the forthcoming Medical Devices Regulation (MDR) would impact manufacturers of drug delivery devices, in a session titled 'New European Medical Device Regulations: Implications for Orally Inhaled and Nasal Drug Products.'
The paper was well-received, with many attendees seeking out Dr. Donawa during the remainder of the conference to seek specific advice relating to their company's products.
Questo sito utilizza i cookies. Utilizzando il nostro sito web l'utente dichiara di accettare e acconsentire all' utilizzo dei cookies in conformità con i termini di uso dei cookies espressi in questo documento.